Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo …
puremagic
1个月前
95
10
已完结
1. 系统已在2026-04-07 10:28:56对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://doi.org/10.1016/S2213-2600(24)00324-2
其他信息:
D Singh, CE Brightling, KF Rabe, MLK Han…
The Lancet Respiratory …, 2025
Elsevier
Background Tezepelumab is a human monoclonal antibody that blocks thymic stromal lymphopoietin, which has shown increased expression in patients with chronic obstructive …
